Screening for imported infections in pediatric patients prior to immunosuppressive therapy

Teresa Del Rosal1, María López-Jorrín2, Ana Méndez-Echevarría3

  • 1General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain; La Paz Research Institute (IdiPAZ), Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Insights

Imported infections are common in children needing immunosuppression, highlighting the need for systematic screening. A structured protocol detected infections like toxoplasmosis and strongyloidiasis in nearly 30% of pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Children undergoing immunosuppressive therapy are at high risk for opportunistic infections.
  • Pre-transplant and pre-chemotherapy screening protocols are crucial for managing infection risks.
  • Identifying imported infections in pediatric populations requires targeted diagnostic approaches.

Purpose of the Study:

  • To determine the prevalence of imported infections in pediatric patients before initiating immunosuppressive therapy.
  • To evaluate the effectiveness of a structured screening protocol in identifying these infections.
  • To assess adherence to the screening protocol and its diagnostic yield.

Main Methods:

  • A retrospective study was conducted on pediatric patients (<18 years) from non-Western countries.
  • Screening occurred between 2020-2024 at a tertiary hospital in Madrid, Spain.
  • The protocol included serology, tuberculosis testing, stool analysis, and vaccination assessment.

Main Results:

  • Sixty-three children were included, primarily from Latin America, with hematologic malignancies or awaiting solid organ transplants.
  • Only 19% of patients completed the full screening protocol.
  • Imported infections were detected in 28.6% of patients, including toxoplasmosis, strongyloidiasis, and malaria. Suboptimal immunity to hepatitis B, measles, and varicella was also noted.

Conclusions:

  • Imported infections are frequent in pediatric patients requiring immunosuppression.
  • Systematic screening prior to immunosuppressive therapy is supported by these findings.
  • Adherence to screening protocols needs improvement to maximize diagnostic yield.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...